These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2499678)
1. The effect of interleukin-2 on parasitemia and myocarditis in experimental Chagas' disease. Hulsebos LH; Choromanski L; Kuhn RE J Protozool; 1989; 36(3):293-8. PubMed ID: 2499678 [TBL] [Abstract][Full Text] [Related]
2. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Michailowsky V; Silva NM; Rocha CD; Vieira LQ; Lannes-Vieira J; Gazzinelli RT Am J Pathol; 2001 Nov; 159(5):1723-33. PubMed ID: 11696433 [TBL] [Abstract][Full Text] [Related]
3. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Chandra M; Tanowitz HB; Petkova SB; Huang H; Weiss LM; Wittner M; Factor SM; Shtutin V; Jelicks LA; Chan J; Shirani J Int J Parasitol; 2002 Jun; 32(7):897-905. PubMed ID: 12062561 [TBL] [Abstract][Full Text] [Related]
4. Structural, ultrastructural studies and evolution of Trypanosoma cruzi-infected mice treated with thioridazine. Paglini-Oliva P; Fernández AR; Fretes R; Peslman A Exp Mol Pathol; 1998 Oct; 65(2):78-86. PubMed ID: 9828149 [TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi strains cause different myocarditis patterns in infected mice. Rodriguez HO; Guerrero NA; Fortes A; Santi-Rocca J; Gironès N; Fresno M Acta Trop; 2014 Nov; 139():57-66. PubMed ID: 25017312 [TBL] [Abstract][Full Text] [Related]
7. IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. Roffê E; Rothfuchs AG; Santiago HC; Marino AP; Ribeiro-Gomes FL; Eckhaus M; Antonelli LR; Murphy PM J Immunol; 2012 Jan; 188(2):649-60. PubMed ID: 22156594 [TBL] [Abstract][Full Text] [Related]
8. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Bellotti G; Bocchi EA; de Moraes AV; Higuchi M L; Barbero-Marcial M; Sosa E; Esteves-Filho A; Kalil R; Weiss R; Jatene A; Pileggi F Am Heart J; 1996 Feb; 131(2):301-7. PubMed ID: 8579025 [TBL] [Abstract][Full Text] [Related]
9. Purinergic Antagonist Suramin Aggravates Myocarditis and Increases Mortality by Enhancing Parasitism, Inflammation, and Reactive Tissue Damage in Novaes RD; Santos EC; Cupertino MC; Bastos DSS; Mendonça AAS; Marques-da-Silva EA; Cardoso SA; Fietto JLR; Oliveira LL Oxid Med Cell Longev; 2018; 2018():7385639. PubMed ID: 30364017 [TBL] [Abstract][Full Text] [Related]
11. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model. Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170 [TBL] [Abstract][Full Text] [Related]
12. A histopathological analysis of the course of myocarditis in C3H/He mice infected with Trypanosoma cruzi clone Sylvio-X10/4. Postan M; Cheever AW; Dvorak JA; McDaniel JP Trans R Soc Trop Med Hyg; 1986; 80(1):50-5. PubMed ID: 3726997 [TBL] [Abstract][Full Text] [Related]
13. The role of fat on cardiomyopathy outcome in mouse models of chronic Trypanosoma cruzi infection. Zaki P; Domingues EL; Amjad FM; Narde MB; Gonçalves KR; Viana ML; de Paula H; de Lima WG; Huang H; Bahia MT; Sherer PE; Dos Santos FM; Weiss LM; Tanowitz HB Parasitol Res; 2020 Jun; 119(6):1829-1843. PubMed ID: 32206887 [TBL] [Abstract][Full Text] [Related]
16. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain. Cevey ÁC; Mirkin GA; Penas FN; Goren NB Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474 [TBL] [Abstract][Full Text] [Related]